MARKET

PHVS

PHVS

Pharvaris N.V.
NASDAQ
34.85
+0.46
+1.34%
Opening 09:59 11/09 EST
OPEN
34.80
PREV CLOSE
34.39
HIGH
35.13
LOW
34.40
VOLUME
43.61K
TURNOVER
--
52 WEEK HIGH
43.25
52 WEEK LOW
21.02
MARKET CAP
2.45B
P/E (TTM)
-11.6559
1D
5D
1M
3M
1Y
5Y
1D
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Immunocore Holdings (IMCR), Pharvaris (PHVS) and Moderna (MRNA)
TipRanks · 1h ago
Weekly Report: what happened at PHVS last week (1102-1106)?
Weekly Report · 5h ago
Weekly Report: what happened at PHVS last week (1026-1030)?
Weekly Report · 11/02 09:03
How Investors Are Reacting To Pharvaris (PHVS) Phase 3 Data Presentation
Simply Wall St · 10/30 14:34
This Monolithic Power Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday
Benzinga · 10/30 14:30
This Hilton Hotels Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Benzinga · 10/29 13:09
This Pentair Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Wednesday
Benzinga · 10/28 16:54
Analysts Are Bullish on Top Healthcare Stocks: Pharvaris (PHVS), AgomAb Therapeutics NV ADR (AGMB)
TipRanks · 10/26 13:20
More
About PHVS
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.

Webull offers Pharvaris NV stock information, including NASDAQ: PHVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHVS stock methods without spending real money on the virtual paper trading platform.